Acurx Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company based in Staten Island, NY, specializing in the development of a groundbreaking class of antibiotics. Their focus lies in combating infections caused by bacteria identified as priority pathogens by esteemed organizations such as the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.
With a commitment to addressing the urgent need for effective antibiotics, Acurx Pharmaceuticals aims to revolutionize the treatment of bacterial infections through innovative research and development. As a publicly held company, they strive to make a significant impact on public health by providing novel solutions to combat antibiotic-resistant bacteria.
Generated from the website